Public company
AIM ImmunoTech Inc.
AIMCIK 0000946644
Price$0.16
1 year-90.8%
Disclosed transactions3
Buys / sells3 / 0
Max Insider Score37
Connections with evidence3
AIM · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 29 | Equels Thomas KDirector, CEO & President | AIMAIM ImmunoTech Inc. Open-market purchase | BUY | $3,167 20.3K sh | Nov 6, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
- ← Insider ofevidenceEquels Thomas KDirector, CEO & President · Oct 23, 2026
- ← Lobbied forevidenceBUCHANAN INGERSOLL & ROONEY PCLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026